D-0066-2024 Class III Ongoing
FDA drug recall D-0066-2024 was initiated by West-Ward Columbus Inc on Sep 22, 2023 and is designated Class III. Reason for recall: Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring. The recall status is ongoing. Affected quantity: 2,673 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 1, 2023
- Initiation Date
- Sep 22, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,673 cartons
Product description
Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724. NDC: 0054-8550-25
Reason for recall
Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.
Distribution pattern
MS, OH
Code information
Lot, expiry: Lot AB7486B, exp Dec 2023; Lot AB8766B, exp April 2024; Lot AB9484B, exp Aug 2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0066-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026